United States · FDA National Drug Code directory
CEFIXIME
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 67877-584_30690cba-b831-45c1-b799-a013d6cfc2db
- Product NDC
- 67877-584
- Form
- CAPSULE
- Composition / generic term
- CEFIXIME
- Labeler
- Ascend Laboratories, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20181012
- Source listing expiry
- 20261231
Source-listed ingredients
- CEFIXIME — 400 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE in 1 BOTTLE (67877-584-01) · 67877-584-01
- 500 CAPSULE in 1 BOTTLE (67877-584-05) · 67877-584-05
- 10 BLISTER PACK in 1 CARTON (67877-584-33) / 10 CAPSULE in 1 BLISTER PACK · 67877-584-33
- 50 CAPSULE in 1 BOTTLE (67877-584-50) · 67877-584-50
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →